Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
A U.S. federal court has officially ordered Philips to restrict the production and sale of its CPAP and BiPAP ventilators for sleep apnea. The move is the culmination of a years-long international ...
The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results